---
figid: PMC4868686__oncotarget-07-5289-g006
figlink: /pmc/articles/PMC4868686/figure/F6/
number: F6
caption: 1. In absence of OCC-MPs, integrins, αV and β3 subunits present on the EC
  membrane, remain inactivated 2. OCC-MPs interact with integrins through lactadherin,
  expressed by EC, and phosptidylserine (PS) present on OCC-MPs surface. 3. Internalization
  of OCC-MP into the EC creates 2 different activations, (i) Extracellularly, metallprotinase
  matrix of the OCC-MP destructs VE-Cadherin in the adherent junction and leads to
  the translocalization of β-catenin from the membrane to the cytoplasm. (ii) Intracellularly,
  OCC-MP activates Rac1, which induces polymerization of the stress fibers and the
  further phosphorylation of β-catenin 4. Free β-catenin accumulates in the cytoplasm
  5. β-catenin is phosphorylated by PAK1/Rac1 pathway on 2 phosphorylation sites Ser552-Ser675
  and by Akt on the phosphorylation site Ser552. 6. The phosphorylated β-catenin is
  translocated to the nucleus where it interacts with the transcription factors TCF/LEF1.
  7. The interaction with TCF/LEF1 leads to the up-regulation of Wnt/β-catenin target
  genes and the mesenchymal markers. This activation promotes proliferation, migration
  and tube formation. In the off state of Wnt/β-catenin pathway, the destruction complex
  (APC, Axin, GSK3 and CK1) in the cytoplasm binds and phosphorylates β-catenin at
  2 phosphorylation sites Ser33-37 and T41-S45. β-catenin is then ubiquinated and
  degraded by proteasomes.
pmcid: PMC4868686
papertitle: VE-cadherin cleavage by ovarian cancer microparticles induces β-catenin
  phosphorylation in endothelial cells.
reftext: Hamda Al Thawadi, et al. Oncotarget. 2016 Feb 2;7(5):5289-5305.
pmc_ranked_result_index: '171890'
pathway_score: 0.8016406
filename: oncotarget-07-5289-g006.jpg
figtitle: VE-cadherin cleavage by ovarian cancer microparticles induces Beta-catenin
  phosphorylation in endothelial cells
year: '2016'
organisms:
- Homo sapiens
ndex: 6507022f-df2a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4868686__oncotarget-07-5289-g006.html
  '@type': Dataset
  description: 1. In absence of OCC-MPs, integrins, αV and β3 subunits present on
    the EC membrane, remain inactivated 2. OCC-MPs interact with integrins through
    lactadherin, expressed by EC, and phosptidylserine (PS) present on OCC-MPs surface.
    3. Internalization of OCC-MP into the EC creates 2 different activations, (i)
    Extracellularly, metallprotinase matrix of the OCC-MP destructs VE-Cadherin in
    the adherent junction and leads to the translocalization of β-catenin from the
    membrane to the cytoplasm. (ii) Intracellularly, OCC-MP activates Rac1, which
    induces polymerization of the stress fibers and the further phosphorylation of
    β-catenin 4. Free β-catenin accumulates in the cytoplasm 5. β-catenin is phosphorylated
    by PAK1/Rac1 pathway on 2 phosphorylation sites Ser552-Ser675 and by Akt on the
    phosphorylation site Ser552. 6. The phosphorylated β-catenin is translocated to
    the nucleus where it interacts with the transcription factors TCF/LEF1. 7. The
    interaction with TCF/LEF1 leads to the up-regulation of Wnt/β-catenin target genes
    and the mesenchymal markers. This activation promotes proliferation, migration
    and tube formation. In the off state of Wnt/β-catenin pathway, the destruction
    complex (APC, Axin, GSK3 and CK1) in the cytoplasm binds and phosphorylates β-catenin
    at 2 phosphorylation sites Ser33-37 and T41-S45. β-catenin is then ubiquinated
    and degraded by proteasomes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT3
  - WNT2
  - WNT4
  - AKT3
  - FZD1
  - WNT8B
  - FZD6
  - WNT10B
  - WNT11
  - WNT2B
  - WNT1
  - WNT16
  - AKT1
  - WNT10A
  - WNT5A
  - WNT3A
  - WNT6
  - WNT7A
  - FZD4
  - WNT8A
  - AXIN2
  - CTNNB1
  - CHKA
  - MYC
  - WNT9A
  - WNT9B
  - MMP9
  - WNT5B
  - TP53
  - FZD2
  - FZD5
  - WNT7B
  - TUBE1
  - CDH5
  - GSK3A
  - GSK3B
  - LEF1
  - LRP5
  - MMP1
  - FZD7
  - FZD8
  - FZD9
  - PAK1
  - RAC1
  - FZD3
  - MFAP1
  - APC
  - VEGFD
  - PGF
  - VEGFA
  - VEGFB
  - VEGFC
  - AXIN1
  - AKT2
  - MMP2
  - FZD10
  - CCND1
  - TEK
  - MMP7
  - Ser
  - Cancer
genes:
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: CKI
  symbol: CKI
  source: hgnc_alias_symbol
  hgnc_symbol: CHKA
  entrez: '1119'
- word: C-MYC
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: MMP2/MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: TUBE
  symbol: TUBE
  source: hgnc_alias_symbol
  hgnc_symbol: TUBE1
  entrez: '51175'
- word: VE-Cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: LEF1
  symbol: LEF1
  source: hgnc_symbol
  hgnc_symbol: LEF1
  entrez: '51176'
- word: LRP5
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: MMP1
  symbol: MMP1
  source: hgnc_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: PAK1
  symbol: PAK1
  source: hgnc_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: Rac1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MMP2/MMP9
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: TIE2
  symbol: TIE-2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: MMP7
  symbol: MMP7
  source: hgnc_symbol
  hgnc_symbol: MMP7
  entrez: '4316'
chemicals:
- word: Ser
  source: MESH
  identifier: D012694
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4868686__F6
redirect_from: /figures/PMC4868686__F6
figtype: Figure
---
